Psychomotor effects of the anxiolytic abecarnil: A comparison with lorazepam

Psychopharmacology

Volumn 131, Issue 2, 1997, Pages 101-107

  Hege, Steven G ^a   Ellinwood Jr , Everett H ^a   Wilson, William H ^a   Helligers, Caroline A M ^a   Graham, Stephen M ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Sandoz Pharma Ltd   (Switzerland)

Author keywords

Carboline; Abecarnil; Anxiolytic; Benzodiazepine; Cognitive tasks; Humans; Pharmacodynamics; Psychomotor skills

Indexed keywords

ABECARNIL; ANXIOLYTIC AGENT; BENZODIAZEPINE RECEPTOR; LORAZEPAM;

ACCURACY; ADULT; ARTICLE; ATAXIA; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG RECEPTOR BINDING; HUMAN; HUMAN EXPERIMENT; MALE; MOTOR COORDINATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; REACTION TIME; RECALL; TASK PERFORMANCE; VERTIGO; VISUAL DISORDER;

ADULT; ANTI-ANXIETY AGENTS; CARBOLINES; COGNITION; DOUBLE-BLIND METHOD; HUMANS; LORAZEPAM; MALE; PSYCHOMOTOR PERFORMANCE; REACTION TIME;

EID: 0030946578     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050271     Document Type: Article

References (39)

1. Ballenger JC, McDonald S, Noyes R, Rickels K, Sussman N, Woods S, Patin J, Singer J (1991) The first double-blind, placebo controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder. Psychopharmacol Bull 27:171-179
2. Christensen LQ, Nielsen LM, Nielsen SL (1990) Traffic accidents and drivers suspected for drug influence. Forens Sci 45:273-280
3. Coenen AML, Stephens DN, Van Luijtelaar ELJM (1992) Effects of the β-carboline abecarnil on epileptic activity, EEG, sleep and behavior of rats. Pharmacol Biochem Behav 42:410-405
4. Cowley DS, Dunner DL (1991) Benzodiazepines in anxiety and depression. In: Roy-Byrne PP, Cowley DS (eds) Benzodiazepines in clinical practice: risks and benefits. American Psychiatric Press, Washington, D.C.
5. Curran HV, Schiwy W, Lader M (1987) Differential amnesic properties of benzodiazepines: a dose-dependent comparison of two drugs with similar elimination half-lives. Psychopharmacology 92:358-364
6. Duka T, Schütt B, Krause W, Dorow R, McDonald S, Fichte K (1993) Human studies on abecarnil a new β-carboline anxiolytic: safety, tolerability and preliminary pharmacological profile. Br J Clin Pharmacol 35:386-394
7. Duncan J (1988) Neuropsychiatric aspects of sedative drug withdrawal. Psychopharmacology 3:171-180
8. Ellinwood EH Jr, Linnoila M, Angle HV, Moore JW Jr, Skinner JT III, Easler M, Molter D (1981) Use of simple tasks to test for impairment of complex skills by a sedative. Psychopharmacology 73:350-354
9. Ellinwood EH Jr, Linnoila M, Easler ME, Molter D (1983) Profile of acute tolerance to three sedative anxiolytics. Psychopharmacology 79:137-141
10. File SE, Bond AJ (1979) Impaired performance and sedation after a single dose of lorazepam. Psychopharmacology 66:309-313
11. Ghoneim MM, Mewaldt SP, Hinrichs JV (1984) Dose-response analysis of the behavioral effects of diazepam. II. Psychomotor performance, cognition and mood. Psychopharmacology 82:296-300
12. Greenblatt DJ, Shader RI (1974) Benzodiazepines in clinical practice. Raven Press, New York
13. Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50-55
14. Homer DW (1991) Benzodiazepines: cognitive and psychomotor effects. In: Roy-Byrne PP, Cowley DS (eds) Benzodiazepines in clinical practice: risks and benefits. American Psychiatric Press, Washington, D.C.
15. Hwang D (1993) ZK 112-119 statistical examination of carry-over effects in a 4×4 Latin square design using the baseline data. Sandoz Pharmaceuticals Corp, East Hanover, N.J.
16. Krause W, Schütt B, Duka T (1990) Pharmacokinetics and acute toleration of the β-carboline derivative, abecarnil (ZK 112-119) in man. Drug Res 40:529-532
17. Löscher W, Hönack D, Scherkl R, Hashem A, Frey H (1990) Pharmacokinetics, anticonvulsant efficacy and adverse effects of the β-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs. J Pharmacol Exp Ther 255:541-548
18. Marzi CA, Bisiacchi P, Nicoletti R (1991) Is interhemispheric transfer of visuomotor information asymmetric? Evidence from a meta-analysis. Neuropsychologia 29:1163-1177
19. Merlin G, Lepoittevin L, Turcant A, Mylonas J, Cavellat JF (1991) Responsabilite des neuropsychotropes dans les accidents de la voie publique. Presse Med 20:409-412
20. Mumford GK, Rush GR, Griffiths RR (1995) Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects. J Pharmacol Exp Ther 272:570-580
21. Nikaido AM, Ellinwood EH Jr (1987) Comparison of the effects of quazepam and triazolam on cognitive-neuromotor performance. Psychopharmacology 92:459-464
22. Nikaido AM, Ellinwood HE Jr, Heatherly DG, Dubiw D (1987) Differential CNS effects of diazepam in elderly adults. Pharmacol Biochem Behav 27:273-281
23. Preston CG, Broks P, Traub M, Ward C, Poppleton P, Stahl SM (1988) Effects of lorazepam on memory, attention and sedation in man. Psychopharmacology 95:208-215
24. Rickels K (1983) Benzodiazepines in the treatment of anxiety: North American experience. In: Costa E (ed) The benzodiazepines, from molecular biology to clinical practice. Raven Press, New York, pp 295-310
25. Roy-Byrne PP (1991) Benzodiazepines: dependence and withdrawal. In: Roy-Byrne PP, Cowley DS (eds) Benzodiazepines in clinical practice: risks and benefits. American Psychiatric Press, Washington, D.C.
26. Sanger DJ, Perrault G, Morel E, Joly D, Zivkovic B (1991) Animal models of anxiety and the development of novel anxiolytic drugs. Prog Neuro-Psychopharmacol Biol Psychiatry 15: 205-212
27. Sannerud CA, Ator NA, Griffiths RR (1993) Behavioral pharmacology of abecarnil in baboons: reduced dependence and abuse potential. Psychopharmacol Ser 11:113-120
28. SAS Institute (1988) SAS/STAT user's guide, release 6.03 edn. SAS Institute, Cary, N.C.
29. Seppälä T, Kortilla K, Häkkinen S, Linnoila M (1976) Residual effects and skills related to driving after a single oral administration of diazepam, midazepam or lorazepam. Br J Clin Pharmacol 3:831-841
30. Shader RI, Dreyfuss D, Gerrein JR, Harmatz JS, Allison SJ, Greenblatt DJ (1986) Sedative effect and impairment learning and recall after single doses of lorazepam. Clin Pharmacol Ther 39:526-529
31. Sheehan DV (1987) Benzodiazepines in panic disorder and agoraphobia. J Affect Disord 13:169-181
32. Stephens DN, Schneider HH, Kehr W, Andrews JS, Rettig KJ, Turski L, Schmeichen R, Turner JD, Jensen LH, Petersen EN, Honore T, Hansen JB (1990) Abecarnil, a metabolically stable anxioselective β-carboline acting at benzodiazepine receptors. J Pharmacol Exp Ther 253:334-343
33. Steppuhn KG, Schneider HH, Turski L, Stephens DN (1993) Long term treatment with abecarnil does not induce diazepam-like dependence in mice. J Pharmacol Exp Ther 264:1395-1400
34. Swift CG (1984) Postural instability as a measure of sedative drug response. Br J Clin Pharmacol 18:87S-90S
35. Turski L, Stephens DN (1993) Effect of the β-arboline abecarnil on spinal reflexes in mice and on muscle tone in genetically spastic rats: a comparison with diazepam. J Pharmacol Exp Ther 267:1215-1220
36. Turski L, Stephens DN, Jensen LH, Petersen EN, Meldrum BS, Patel S, Hansen JB, Löscher W, Schneider HH, Schmeichen R (1990) Anticonvulsant action of the β-carboline abecarnil: studies in rodents and baboon, Papio papio. J Pharmacol Exp Ther 253:344-352
37. Weschler D (1981) Weschler adult intelligence scale-revised manual. The Psychological Corp., Cleveland, O.H.
38. Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGraw-Hill, New York
39. Wittenborn JR (1979) Effects of benzodiazepines in psychomotor performance. Br J Clin Pharmacol 7:61S-67S